Westport investors in $37M deal for Farmington biotech

Westport investors in $37M deal for Farmington biotech


A Westport venture capital fund is among the investors in Rallybio, a Farmington startup that announced on Wednesday initial funding totaling $37 million under former research heads of Alexion Pharmaceuticals. RallyBio is developing drugs for rare diseases, with investors including Canaan Partners in Westport, 5AM Ventures in Boston, New Leaf Venture Partners in New York City, and the state-backed Connecticut Innovations fund in Rocky Hill.



from Biotech News